Aquestive Therapeutics, Inc. (AQST)
NASDAQ: AQST · Real-Time Price · USD
2.650
+0.070 (2.71%)
Mar 7, 2025, 4:00 PM EST - Market closed

Aquestive Therapeutics Stock Forecast

Stock Price Forecast

The 7 analysts with 12-month price forecasts for Aquestive Therapeutics stock have an average target of 10.57, with a low estimate of 7.00 and a high estimate of 17. The average target predicts an increase of 298.87% from the current stock price of 2.65.

Analyst Consensus: Strong Buy
Target Low Average Median High
Price $7.00 $10.57 $10 $17
Change +164.15% +298.87% +277.36% +541.51%

Analyst Ratings

The average analyst rating for Aquestive Therapeutics stock from 7 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating Oct '24Nov '24Dec '24Jan '25Feb '25Mar '25
Strong Buy 222222
Buy 556665
Hold 000000
Sell 000000
Strong Sell 000000
Total 778887

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
Lake Street
Lake Street
Strong Buy
Maintains
$10$8
Strong Buy Maintains $10$8 +201.89% Mar 7, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$10
Strong Buy Reiterates $10 +277.36% Dec 20, 2024
Cantor Fitzgerald
Cantor Fitzgerald
Buy
Initiates
$17
Buy Initiates $17 +541.51% Dec 17, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$10
Strong Buy Reiterates $10 +277.36% Nov 11, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$10
Strong Buy Reiterates $10 +277.36% Nov 6, 2024
More Analyst Ratings

Financial Forecast

Revenue This Year
54.01M
from 57.56M
Decreased by -6.17%
Revenue Next Year
73.30M
from 54.01M
Increased by 35.72%
EPS This Year
-0.62
from -0.51
EPS Next Year
-0.54
from -0.62
Fiscal Year FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026 FY 2027
Period Ending Dec 31, 2020 Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026 Dec 31, 2027
Revenue
45.85M50.83M47.68M50.58M57.56M54.01M73.30M140.22M
Revenue Growth
-12.85%10.87%-6.20%6.09%13.80%-6.17%35.72%91.30%
EPS
-1.66-1.85-1.12-0.13-0.51-0.62-0.54-0.09
EPS Growth
--------
Forward PE
--------
No. Analysts -----1173
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20252026202720282029
High 65.1M 92.8M 158.6M
Avg 54.0M 73.3M 140.2M
Low 41.5M 45.1M 124.1M

Revenue Growth

Revenue Growth 20252026202720282029
High
13.1%
71.9%
116.3%
Avg
-6.2%
35.7%
91.3%
Low
-28.0%
-16.5%
69.3%

EPS Forecast

EPS 20252026202720282029
High -0.50 -0.27 -0.09
Avg -0.62 -0.54 -0.09
Low -0.76 -0.71 -0.09

EPS Growth

EPS Growth 20252026202720282029
High - - -
Avg - - -
Low - - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.